Small-animal PET: A promising, non-invasive tool in pre-clinical research.

Schnöckel U, Hermann S, Stegger L, Law M, Kuhlmann M, Schober O, Schäfers K, Schäfers M

Research article (journal) | Peer reviewed

Abstract

Today, non-invasive imaging techniques are significantly contributing to the understanding of molecular processes in vivo. Positron emission tomography (PET) is a scintigraphic medical imaging modality that uses radiolabelled molecules (tracers), provides quantitative tomographic images and allows non-invasive assessment of the biodistribution of radioactive substances in vivo. The assessment of pathological glucose metabolism is the clinically best-established application of PET today; however, a multitude of different tracers are available to assess diverse physiological processes. The growing interest in pre-clinical imaging studies, in biological and medical basic research, as well as in pharmaceutical research, has fostered the recent growth in small-animal PET. Small-animal PET can be applied to enable the transfer from molecular findings in vitro to in vivo applications in humans, from bench to bed side.

Details about the publication

JournalEuropean journal of pharmaceutics and biopharmaceutics (Eur J Pharm Biopharm)
Volume74
Issue1
Page range50-54
StatusPublished
Release year2010
Language in which the publication is writtenEnglish
DOI10.1016/j.ejpb.2009.05.012

Authors from the University of Münster

Hermann, Sven
Clinic for Nuclear Medicine
Kuhlmann, Michael
European Institute of Molecular Imaging (EIMI)
Schäfers, Klaus
European Institute of Molecular Imaging (EIMI)
Schäfers, Michael
Clinic for Nuclear Medicine
European Institute of Molecular Imaging (EIMI)
Schnöckel, Uta
Clinic for Nuclear Medicine
Schober, Otmar
Clinic for Nuclear Medicine